您目前所在的位置:首页>讲者视频>Evaluation for the safety and efficacy using mesenchymal stem cell in treating severe and critically ill COVID-19 patients in China: a multicenter, open-label, non-randomised, and parallel controlled exploratory trial
标题:Evaluation for the safety and efficacy using mesenchymal stem cell in treating severe and critically ill COVID-19 patients in China: a multicenter, open-label, non-randomised, and parallel controlled exploratory trial